Literature DB >> 26161611

Levels of Salivary Immunoglobulin A (SIgA) in HIV Infected Children.

P Subramaniam1, K Kumar1, K L Girish Babu1.   

Abstract

UNLABELLED: Secretory IgA is the main type of immunoglobulin in saliva and is considered to be the main secretion factor of adaptive immunity in the mouth.
OBJECTIVE: To assess the effect of Anti Retroviral Therapy on SIgA levels in saliva of HIV infected children. STUDY
DESIGN: A cross-sectional sample of 50 HIV infected children aged 6-8 years were divided into 2 groups ; Group 1: children prior to onset of anti-retroviral therapy and Group 2: children undergoing anti-retroviral therapy. Stimulated whole saliva samples were collected from each child following I hour of breakfast. The samples were placed on ice packs and immediately transferred to a laboratory, processed and total SIgA quantification was estimated using ELISA. Data obtained was statistically analyzed.
RESULTS: Among HIV infected children, significantly low SIgA levels of 6.2 mg/dl was seen in children prior to ART.
CONCLUSION: Salivary IgA levels were significantly low in HIV infected children, particularly in children prior to ART.

Entities:  

Keywords:  ART; HIV; dental caries; salivary IgA

Mesh:

Substances:

Year:  2015        PMID: 26161611     DOI: 10.17796/1053-4628-39.4.377

Source DB:  PubMed          Journal:  J Clin Pediatr Dent        ISSN: 1053-4628            Impact factor:   1.065


  2 in total

Review 1.  Oral Health Status of Children and Adolescents Living with HIV Undergoing Antiretroviral Therapy: A Systematic Review and Meta-Analysis.

Authors:  Phoebe Pui Ying Lam; Ni Zhou; Hai Ming Wong; Cynthia Kar Yung Yiu
Journal:  Int J Environ Res Public Health       Date:  2022-10-08       Impact factor: 4.614

Review 2.  Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and Meta-Analysis.

Authors:  Phoebe Pui Ying Lam; Ni Zhou; Cynthia Kar Yung Yiu; Hai Ming Wong
Journal:  Int J Environ Res Public Health       Date:  2022-09-21       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.